Advertisement

Oxytocin Injection

[08 July 2016]

Products Affected - Description

Oxytocin injection, Fresenius Kabi
10 unit/mL, 30 mL vial, 10 count (NDC 63323-0012-30)

Reason for the Shortage

  • Fresenius Kabi states the shortage was due to increased demand.
  • Par Sterile Products (formerly JHP) discontinued generic oxytocin injection in July 2014. Par Sterile Products discontinued Pitocin 10 unit/mL 50 mL vials in September 2015.
  • West-Ward is not actively marketing oxytocin.

Available Products

Pitocin injection, Par Sterile Products
10 unit/mL, 1 mL vial, 25 count (NDC 42023-0116-25)
10 unit/mL, 10 mL vial, 1 count (NDC 42023-0116-01)
10 unit/mL, 10 mL vial, 25 count (NDC 42023-0116-02)
 
Oxytocin injection, Fresenius Kabi
10 unit/mL, 1 mL vial, 25 count (NDC 63323-0012-01)
10 unit/mL, 10 mL vial, 25 count (NDC 63323-0012-10)

Estimated Resupply Dates

Fresenius Kabi has oxytocin 30 mL vials on back order and the company estimates a release date of mid-July 2016.

Related Shortages

Updated

July 8, May 24 and 11, April 28, February 2, 2016; December 11, November 20, October 19, 5 and 1, August 5, June 1, April 21, 16 and 2, March 16, February 25 and 11, January 16 and 7, 2015; December 18 and 1, October 20, September 18 and 9, August 6, July 18, June 12, May 27 and 5, April 3, March 27 and 6, January 24, 2014; December 18 and 4, November 27 and 14, October 30 and 15, August 13, July 23 and 2, June 19, April 26, March 29 and 15, February 27, January 30 and 16, 2013; December 14, November 16, September 24, August 23 and 10, June 15, May 17 and 7, April 27 and 10, March 23 and 9, February 23, 2012; December 22, 2011, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing